Convenient Cyclopentadiene Modifications for Building Versatile (Radio‐)Metal Cyclopentadienyl Frameworks

Rapid and General Access to α-Haloketones Using Quaternary Ammonium Salts as Halogen Sources

A general, rapid, and scalable method for the preparation of α-halogenated ketones using N-alkenoxypyridinium salts as substrates and quaternary ammonium salts as halogen sources was developed, featuring mild reaction conditions, excellent functional group tolerance, short reaction times, and a wide substrate scope.

Organometallic small molecule kinase inhibitors - direct incorporation of Re and 99mTc into Opaganib®

[(η5-Cp)Re^I(CO)₃] was incorporated into the kinase inhibitor Opaganib®. The resulting bioorganometallic complex showed a similar anti-cancer activity to Opaganib® against PC-3 cancer cells. The IC₅₀ value for the kinase SK2 is 30x higher than that of Opaganib®. The ^99mTc homologue was synthesized, completing a matched-pair for molecular theranostics.

Replacing an adamantyl unit in the protein kinase inhibitor Opaganib® with an integrated [(η⁵-Cp)M(CO)₃] (M = Re, ^99mTc) unit retains the lead's bioactivity and yields a true matched-pair pharmacomimetic.